T1	chemical 32 41	antigenic
T2	chemical 68 75	polymer
T3	chemical 76 84	adjuvant
T4	disease_or_phenotypic_feature 99 105	cancer
T5	disease_or_phenotypic_feature 172 182	depression
T6	chemical 350 359	serotonin
T7	chemical 364 372	dopamine
T8	disease_or_phenotypic_feature 405 426	peripheral neuropathy
T9	chemical 440 444	drug
T10	disease_or_phenotypic_feature 458 468	hypertonia
T11	chemical 473 483	anesthesia
T12	disease_or_phenotypic_feature 487 504	Angelman syndrome
T13	disease_or_phenotypic_feature 574 583	malignant
T14	chemical 620 627	mixture
T15	disease_or_phenotypic_feature 646 655	malignant
T16	chemical 685 690	water
T17	chemical 709 713	acid
T18	disease_or_phenotypic_feature 753 766	renal failure
T19	chemical 771 775	date
T20	disease_or_phenotypic_feature 804 807	HCC
T21	chemical 866 874	antigens
T22	chemical 876 885	Oxidative
T23	disease_or_phenotypic_feature 908 915	obesity
T24	disease_or_phenotypic_feature 919 932	breast cancer
T25	disease_or_phenotypic_feature 945 958	ovarian cysts
T26	chemical 1039 1049	biomarkers
T27	chemical 1062 1068	oxygen
T28	disease_or_phenotypic_feature 1165 1182	cerebral ischemia
T29	disease_or_phenotypic_feature 1191 1208	cerebral ischemia
T30	chemical 1332 1348	antigen-specific
T31	disease_or_phenotypic_feature 1469 1480	hyperplasia
T32	disease_or_phenotypic_feature 1545 1553	melanoma
T33	chemical 1565 1572	antigen
T34	disease_or_phenotypic_feature 1628 1651	undifferentiated/poorly
T35	disease_or_phenotypic_feature 1628 1666	undifferentiated/poorly differentiated
T36	disease_or_phenotypic_feature 1667 1691	nasopharyngeal carcinoma
T37	chemical 1719 1725	proton
T38	disease_or_phenotypic_feature 1822 1831	hamartoma
T39	chemical 1850 1864	growth hormone
T40	disease_or_phenotypic_feature 1880 1909	hypogonadotropic hypogonadism
T41	chemical 1927 1935	estrogen
T42	disease_or_phenotypic_feature 1963 1985	metabolic bone disease
T43	chemical 2026 2034	estrogen
T44	chemical 2103 2111	antigens
T45	disease_or_phenotypic_feature 2115 2126	lung cancer
T46	disease_or_phenotypic_feature 2191 2202	lung cancer
T47	chemical 2252 2255	LCM
T48	disease_or_phenotypic_feature 2294 2301	seizure
T49	disease_or_phenotypic_feature 2313 2320	vertigo
T50	disease_or_phenotypic_feature 2322 2328	ataxia
T51	chemical 2368 2375	enzymes
T52	chemical 2389 2399	inhibitors
T53	chemical 2408 2415	glucose
T54	disease_or_phenotypic_feature 2436 2449	hyperglycemia
T55	disease_or_phenotypic_feature 2473 2480	alcohol
T56	chemical 2473 2480	alcohol
T57	disease_or_phenotypic_feature 2494 2502	diabetes
T58	disease_or_phenotypic_feature 2507 2514	obesity
T59	chemical 2580 2584	drug
T60	disease_or_phenotypic_feature 2650 2657	pan-RAF
T61	chemical 2658 2667	inhibitor
T63	corrected_chemical 26 50	tumor antigenic peptides
R1	treats Arg1:T63 Arg2:T4	
T64	corrected_chemical 430 444	injection drug
R4	causes_or_contributes_to Arg1:T64 Arg2:T8	
T65	missed_disease_or_phenotypic_feature 1106 1118	brain injury
T66	corrected_chemical 1051 1068	Hyperbaric oxygen
T67	corrected_disease_or_phenotypic_feature 1159 1182	focal cerebral ischemia
T68	corrected_disease_or_phenotypic_feature 1184 1208	global cerebral ischemia
T69	missed_disease_or_phenotypic_feature 1210 1235	neonatal hypoxia-ischemia
T70	missed_disease_or_phenotypic_feature 1240 1263	subarachnoid hemorrhage
R5	treats Arg1:T66 Arg2:T65	
R6	treats Arg1:T66 Arg2:T67	
R7	treats Arg1:T66 Arg2:T68	
R8	treats Arg1:T66 Arg2:T69	
R9	treats Arg1:T66 Arg2:T70	
T71	missed_chemical 1265 1271	Î”pep27
T72	missed_disease_or_phenotypic_feature 1317 1320	AAD
R10	treats Arg1:T71 Arg2:T72	
T73	corrected_disease_or_phenotypic_feature 1457 1480	goblet cell hyperplasia
R11	treats Arg1:T71 Arg2:T73	
T74	missed_disease_or_phenotypic_feature 1403 1413;1428 1451	peripheral eosinophil accumulation
R12	treats Arg1:T71 Arg2:T74	
T76	corrected_disease_or_phenotypic_feature 1418 1451	pulmonary eosinophil accumulation
R13	treats Arg1:T71 Arg2:T76	
T78	corrected_chemical 1702 1725	double-scattered proton
T81	corrected_chemical 1911 1950	Combinations of estrogen and progestins
R18	treats Arg1:T81 Arg2:T88	
T83	corrected_chemical 2383 2399	SGLT2 inhibitors
T84	missed_disease_or_phenotypic_feature 2453 2461	diabetes
R19	treats Arg1:T83 Arg2:T54	
R20	treats Arg1:T83 Arg2:T84	
T85	corrected_chemical 2650 2667	pan-RAF inhibitor
T86	disease_or_phenotypic_feature 2685 2702	colorectal cancer
R21	treats Arg1:T85 Arg2:T86	
T87	missed_chemical 2586 2595	LY3214996
R22	treats Arg1:T87 Arg2:T86	
T88	missed_disease_or_phenotypic_feature 2043 2052	neoplasia
R23	causes_or_contributes_to Arg1:T43 Arg2:T88	
T75	missed_disease_or_phenotypic_feature 2408 2425	glucose excretion
R14	causes_or_contributes_to Arg1:T83 Arg2:T75	
T77	missed_disease_or_phenotypic_feature 2535 2549	liver fibrosis
R24	causes_or_contributes_to Arg1:T56 Arg2:T77	
T89	corrected_chemical 54 84	biodegradable-polymer adjuvant
R25	treats Arg1:T89 Arg2:T4	
R2	treats Arg1:T41 Arg2:T42	
T90	missed_chemical 1940 1950	progestins
R3	treats Arg1:T90 Arg2:T42	
T91	missed_disease_or_phenotypic_feature 2257 2266	myoclonus
T92	missed_disease_or_phenotypic_feature 2271 2280	confusion
T93	missed_disease_or_phenotypic_feature 2337 2375	asymptomatic increase in liver enzymes
R26	causes_or_contributes_to Arg1:T47 Arg2:T91	
R27	causes_or_contributes_to Arg1:T47 Arg2:T92	
R28	causes_or_contributes_to Arg1:T47 Arg2:T48	
R29	causes_or_contributes_to Arg1:T47 Arg2:T49	
R30	causes_or_contributes_to Arg1:T47 Arg2:T50	
R31	causes_or_contributes_to Arg1:T47 Arg2:T93	
R32	causes_or_contributes_to Arg1:T59 Arg2:T77	
R15	treats Arg1:T78 Arg2:T36	
R16	causes_or_contributes_to Arg1:T53 Arg2:T54	
